Search

Search Constraints

You searched for: Author/Creator Esposito, Assunta

Search Results

2. Correlation between BRAF mutational status and clinical response to pembrolizumab in advanced melanoma patients. (4th November 2015)

3. Correlation between BRAF mutational status and clinical response to pembrolizumab in advanced melanoma patients. Issue 2 (December 2015)

4. Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients. (4th November 2015)

5. Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients. Issue 2 (December 2015)

6. Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma. (4th March 2017)

7. High expression of a spliced variant of FKBP51 in peripheral blood mononuclear cells of melanoma patients may be related to PDL-1 on tumour and predictive of response to Ipilimumab. (6th November 2014)

9. Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis. Issue 11 (24th November 2022)

10. NMR‐based metabolomics and bioassays to study phytotoxic extracts and putative phytotoxins from Mediterranean plant species. Issue 5 (20th June 2019)